Share This Page
Details for Patent: 6,098,632
✉ Email this page to a colleague
Summary for Patent: 6,098,632
| Title: | Nicotine-impermeable container and method of fabricating the same | |||||||||||||||||||||||||||||||
| Abstract: | The present invention relates to a nicotine-impermeable container and a method for fabricating same. Additionally, the invention relates to a nicotine inhaling device which allows a user to ingest nicotine vapors orally. The nicotine inhaling device of the present invention is primarily directed to a device which can be used as a smoking cessation aid. | |||||||||||||||||||||||||||||||
| Inventor(s): | James E. Turner, Michael P. Ellis, Ronald G. Oldham, Ira Hill, Bengt Eber Malmborg, Sven-Borje Andersson | |||||||||||||||||||||||||||||||
| Assignee: | McNeil AB | |||||||||||||||||||||||||||||||
| Application Number: | US08/803,555 | |||||||||||||||||||||||||||||||
|
Patent Claim Types: see list of patent claims | Use; Compound; Delivery; | |||||||||||||||||||||||||||||||
| Patent landscape, scope, and claims: | United States Patent 6,098,632: Scope, Claim-Element Breakdown, and U.S. LandscapeWhat does US 6,098,632 claim in plain scope terms?US 6,098,632 is directed to a nicotine delivery system that maintains nicotine integrity during storage (extended shelf life) by enclosing a measured nicotine reservoir in a self-sealed, nicotine-impermeable barrier. The barrier’s nicotine-blocking function comes from a copolymer-based nicotine barrier layer and from continuous sealing geometry created by heat-sealing at least two adjacent surfaces of the barrier layer. Core claim architecture is consistent across independent claim 1 through claim 3, with claim scope differing by the copolymer state/structure used to form the nicotine barrier layer:
Each claim adds the same functional and structural limitations:
What are the exact claim elements and how they constrain infringement?Below is an element-by-element mapping for claims 1 to 3, organized for FTO and design-around analysis. Claim 1 element map (copolymer in general)Claim 1 requires all of the following:
Claim 2 element map (non-crystalline copolymer)Claim 2 is identical to claim 1 except for this material limitation:
Claim 3 element map (amorphous copolymer)Claim 3 is identical to claim 1 except for this material limitation:
Practical infringement boundary: where infringement is easiest vs. hardestEasiest to land on:
Harder to land on:
How broad are claims 1 to 3 relative to each other?Claims 2 and 3 narrow claim 1 by specifying polymer morphology/structure. Relative scope ranking
In practical claim construction, claims 2 and 3 typically cover subsets of copolymers within claim 1’s general category. Claim 1 can read on both crystalline and non-crystalline materials unless “formed essentially of a copolymer” is interpreted narrowly by the intrinsic record (not provided here). Claims 2 and 3 impose explicit morphology limits that can be used for design-around via polymer crystallinity control and characterization. What design choices can move a product outside the asserted scope?The claim language provides several clean, technically actionable “outs.” The most direct are structural/material disconnects. Design-around levers aligned to claim limitations
How the “selectively accessible” nicotine concept affects claim reachAll three claims start with a nicotine delivery system where nicotine is selectively made accessible to a user. The claim text provided does not require a specific delivery mechanism (e.g., wick, membrane, mechanical puncture, diffusion-limited opening). This means the delivery “access” limitation likely functions as an intended use constraint rather than a detailed structural component, unless the patent specification ties it to a particular structure. From an infringement standpoint, the strongest enforceable portion is the sealed reservoir and barrier architecture: reservoir + self-sealed nicotine-impermeable barrier + copolymer barrier layer + heat-sealed continuous seam preventing migration. Claim-structure implications for claim constructionTwo features often drive scope in barrier patents:
What does this imply for a freedom-to-operate posture?Given only the claim language provided, US 6,098,632 is best treated as a seam-sealed, copolymer-barrier nicotine enclosure patent. The highest-risk overlap typically comes from products that:
If a nicotine pouch, cartridge, or micro-reservoir uses these same architectural elements, the probability of mapping to claims 1 to 3 increases quickly. U.S. patent landscape: how this patent typically clustersYou asked for a “patent landscape,” but the only concrete source material provided is the claim text. Without bibliographic data (assignee, filing date, related patents/citations) the landscape cannot be accurately enumerated. Per your constraints, a complete and accurate landscape requires external patent-record data (publication history, CPC/US class mapping, prosecution history, cited references, and family members). No such record data was provided in the prompt, so a definitive landscape cannot be produced without risking factual errors. Actionable risk map derived from the claimsEven without a full landscape of neighboring patents, you can operationalize a risk map based on the elements US 6,098,632 demands. Risk tiers by product architecture
Design-around target matrix
Key Takeaways
FAQs1) Does the patent require a specific nicotine dispensing mechanism?The provided claims require nicotine is “selectively made accessible to a user,” but the provided limitations focus on the sealed reservoir and nicotine barrier architecture rather than specifying a particular dispensing structure. 2) What is the single most critical structural element for infringement risk?The combination of (i) a self-sealed nicotine-impermeable barrier, (ii) a copolymer barrier layer effective to deter migration, and (iii) heat sealing of at least two adjacent surfaces to form a continuous barrier. 3) If a product uses a copolymer barrier but does not heat-seal adjacent surfaces, does it avoid the claims?The claims explicitly require heat sealing of at least two adjacent surfaces to form a continuous nicotine-impermeable barrier. Avoiding that seam method is a direct path to non-infringement on that limitation. 4) How do claims 2 and 3 change enforcement compared with claim 1?Claims 2 and 3 impose morphology constraints on the copolymer barrier layer: “non-crystalline” and “amorphous,” respectively. This can reduce coverage for barriers whose polymer structure does not fit those categories. 5) Is the “extended shelf life” limitation likely to narrow claim coverage?The claims include the shelf-life concept but do not add quantified shelf-life metrics or process steps in the provided claim language. The enforceable limitations remain the sealed nicotine reservoir and barrier structure. References[1] United States Patent 6,098,632, claims 1-3 (as provided in prompt). More… ↓ |
Drugs Protected by US Patent 6,098,632
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,098,632
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 174805 | ⤷ Start Trial | |||
| Australia | 642506 | ⤷ Start Trial | |||
| Australia | 8002791 | ⤷ Start Trial | |||
| Brazil | 9106537 | ⤷ Start Trial | |||
| Canada | 2084771 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
